Indian pharma sector to grow in 2012, rupee fall to benefit: Biocon

  • 10:58
  • Published On: January 09, 2012
Cinema View
Embed
Kiran Mazumdar Shaw, CMD, Biocon told NDTV Profit that they expect to see more mergers and acquisitions in pharmaceutical sector as strong growth projections for Indian markets is a big catalyst. On growth areas in the sector, he said that generics continue to be a very strong growth vertical and expects bio-generic segment to pick up. He added that rupee fall will benefit the sector.

Related Videos

"Historic Moment": Kiran Mazumdar-Shaw On Women's Quota Bill
September 19, 2023 4:19
"Much Needed, Was Long Overdue": Entrepreneur Kiran Mazumdar Shaw
September 18, 2023 1:38
World Health Day Special: Kiran Mazumdar Shaw On How Can India Achieve Health For All
April 06, 2023 8:38
Kiran Mazumdar Shaw's World Health Day Message
April 06, 2023 0:34
Kiran Mazumdar Shaw On Budget Disappointments
February 01, 2022 8:16
"Shouldn't Overreact To Delays In Covaxin Approval": Biocon's Kiran Shaw To NDTV
November 03, 2021 25:09
'Have Had Extraordinary Mentors Throughout': Indra Nooyi
September 28, 2021 6:21
Prannoy Roy Interviews Indra Nooyi, Former PepsiCo Chief, On Her New Book
September 27, 2021 42:45
Coimbatore Senior Citizens’ Podcast Makes Waves
June 16, 2021 1:47
Equitable Access To Vaccines Important: Kiran Mazumdar Shaw
May 06, 2021 12:20
Covid-19 Vaccine Pricing: Private Risk Or Public Funding?
April 30, 2021 4:20
'One Nation, Many Prices' Policy Sparks Controversy
April 30, 2021 2:50
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination